financetom
Business
financetom
/
Business
/
Gyre Therapeutics Low Blood Platelet Treatment Approved in China
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Gyre Therapeutics Low Blood Platelet Treatment Approved in China
Jul 2, 2024 1:47 PM

04:25 PM EDT, 07/02/2024 (MT Newswires) -- Gyre Therapeutics ( GYRE ) said Tuesday it has received approval in China for avatrombopag maleate tablets for the treatment of low blood platelet count associated with chronic liver disease.

The drug is approved for adult patients undergoing elective diagnostic procedures or therapy.

Gyre Therapeutics' ( GYRE ) unit Gyre Pharmaceuticals acquired avatrombopag from Nanjing Healthnice Pharmaceutical Technology in June 2021.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Alphatec Files Secondary Stock Shelf to Cover Exercise of Warrants
Alphatec Files Secondary Stock Shelf to Cover Exercise of Warrants
Nov 15, 2024
04:54 PM EST, 11/15/2024 (MT Newswires) -- Alphatec Holdings ( ATEC ) late Friday filed a registration statement for the resale of up to 1.1 million shares to be issued to L-5 Healthcare Partners if it exercises a warrant received from the company on Nov. 8. The warrant has an exercise price of $2.17 per share. The company will receive...
CRH Acquires Dutra Materials
CRH Acquires Dutra Materials
Nov 15, 2024
04:50 PM EST, 11/15/2024 (MT Newswires) -- CRH (CRH) said late Friday it acquired Dutra Materials in San Rafael, California, to strengthen its Americas Materials Solutions business. The acquisition improves CRH's operations in the Western US by adding strategic aggregate reserves and asphalt production capacity, supporting the growing demands of the region's construction market, the company said. ...
Gladstone Capital COO Terry Lee Brubaker to Retire
Gladstone Capital COO Terry Lee Brubaker to Retire
Nov 15, 2024
04:45 PM EST, 11/15/2024 (MT Newswires) -- Gladstone Capital ( GLAD ) Chief Operating Officer Terry Lee Brubaker will retire, effective Dec. 2. Brubaker is also retiring as director and executive officer of Gladstone Management and as a member of the board of managers and an executive officer of Gladstone Administration, Gladstone Capital ( GLAD ) said Friday in a...
Patrick Industries Raises Quarterly Dividend, Share Buyback Program
Patrick Industries Raises Quarterly Dividend, Share Buyback Program
Nov 15, 2024
04:52 PM EST, 11/15/2024 (MT Newswires) -- Patrick Industries ( PATK ) said late Friday that its board has approved an increase in its quarterly dividend to $0.60 per share from $0.55 per share, payable on Dec. 9 to shareholders of record on Nov. 25. The board also approved an increase in the amount of the shares that may be...
Copyright 2023-2026 - www.financetom.com All Rights Reserved